Louise Wagner Noergaard

Title: Louise Wagner Noergaard: Innovator in Drug Dosage Optimization

Introduction

Louise Wagner Noergaard is a prominent inventor based in Valby, Denmark. She has made significant contributions to the field of medical technology, particularly in optimizing drug dosage regimens. Her innovative approach aims to enhance patient care through precise insulin management.

Latest Patents

Louise holds a patent for a "System for optimizing a drug dosage regimen over time." This system is designed to optimize a patient's basal insulin dosage regimen by determining from blood glucose values whether and by how much to adjust the recommended amount of insulin. The goal is to maintain future blood glucose levels within a predefined range. Notably, the system disregards certain blood glucose values if no patient-actuated operation indicative of insulin administration has been detected within a specified timeframe.

Career Highlights

Louise is currently employed at Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. Her work focuses on developing innovative solutions that improve the management of diabetes and enhance patient outcomes.

Collaborations

Louise collaborates with talented professionals in her field, including Toke Folke Christensen and Mads Schenstroem Stefansen. Their combined expertise contributes to the advancement of medical technologies and the optimization of treatment protocols.

Conclusion

Louise Wagner Noergaard's contributions to drug dosage optimization reflect her commitment to improving patient care through innovation. Her work at Novo Nordisk A/S and her patented system exemplify the impact of technology in healthcare.